Invetech Expands IVD Contract Manufacturing Offering to the United States
Invetech, a leader in new product development, custom automation and contract manufacturing, today announced the formal ISO 13485 certification of its in vitro diagnostics (IVD) manufacturing center in Boxborough, MA. This achievement expands the company’s global IVD contract manufacturing footprint into the United States while complementing the well-established manufacturing capabilities of its facility in Melbourne, Australia.
In addition to its IVD instrument manufacturing accreditation, Invetech’s Dover Motion facility in Boxborough will continue to operate as an ISO 9001 accredited design and manufacturing center for the supply of precision motion solutions and subsystems for diagnostics instruments.
“Achieving this accreditation builds on Dover Motion’s 50 years of experience designing and manufacturing precision motion systems for life sciences, diagnostics and factory automation industries,” said Ankush Kaul, General Manager of Invetech’s Dover Motion division and Global Vice President of Contract Manufacturing. “It also furthers our commitment to providing a full-service product realization offering, from concept to long-term manufacturing.”
In anticipation of this accreditation, Invetech has established a pipeline of IVD instrument contract manufacturing projects to be manufactured in the Boxborough facility.
“Invetech has a long track record of successful IVD instrument manufacture for global diagnostics companies including Abbott, Bio-Rad and bioMérieux,” said Andreas Knaack, President of Invetech. “Our track record in IVD, use of Fortive Business System (FBS) tools to continuously improve quality and on-time delivery, and now providing a contract manufacturing offering in closer proximity to our clients will increase accessibility and collaboration between teams to deliver improved outcomes now and in the future.”
About Invetech
Invetech is your trusted partner in solving complex manufacturing and product development challenges in the global advanced therapies market. For more than three decades, we’ve partnered with leaders in diagnostics, life sciences, and cell therapy to co-create breakthrough solutions that transform ideas into market-ready technologies and therapies. Whether transitioning from early process development to commercial-scale manufacturing or optimizing complex workflows, our team combines scientific insight, engineering excellence and proven technology platforms to deliver tailored solutions. Our proven modules, technology platforms and custom automation solutions integrate seamlessly with your processes, reducing time to market, and supporting scalable, GMP-compliant manufacturing. Together with our clients, we’re advancing healthcare.
To learn more about Invetech Group, visit https://www.invetechgroup.com/
For more information contact:
Emily Ellinger, Marketing &
Communications Manager,
Invetech
emily.ellinger@invetech.com.au
